High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)266-267
Number of pages2
JournalInternational Journal of Cardiology
Volume250
DOIs
StatePublished - Jan 1 2018

Funding

Dr. Pepine receives support from the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine; NIH/NHLBI--UFRCC for the Cardiovascular Cell Therapy Research Network and Training Core Supplement HL087366, Brain-Gut Microbiome-Immune Axis in Hypertension HL132448, and Angiotensin and Neuroimmune Activation in Hypertension HL033610; US Dept. of Defense CDRMP Ischemia-Intensive Medical Treatment Reduces Events in Women with Nonobstructive CAD PR161603; NIH NCATS—University of Florida Clinical and Translational Science UL1TR001427; and PCORnet-OneFlorida Clinical Research Consortium CDRN-1501-26,692.

FundersFunder number
Avedisian School of Medicine Department of Medicine
Gatorade Trust
NIH NCATS
UFRCCHL087366, HL132448
Clinical and Translational Science Institute, University of FloridaUL1TR001427
National Institutes of Health (NIH)
U.S. Department of Defense
National Heart, Lung, and Blood Institute (NHLBI)
Florida AandM University and Florida State University

    Keywords

    • Coronary heart disease
    • hsTroponin I
    • hsTroponin T
    • Risk prediction

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?'. Together they form a unique fingerprint.

    Cite this